No Data
No Data
H.C. Wainwright Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Raises Target Price to $10
Express News | Sangamo Therapeutics Inc : H.c. Wainwright Raises Target Price to $10 From $5
Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Individual Investors Who Own 55% Along With Institutions Invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Saw Increase in Their Holdings Value Last Week
Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday
There's Reason For Concern Over Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Massive 61% Price Jump
No Data
No Data